Cargando…

OR11-3 Evidence for Preserved Ovarian Reserve in Transgender Men Receiving Testosterone Therapy: Anti-Mullerian Hormone Serum Levels Decrease Modestly after One Year of Treatment

Background: Although successful pregnancies carried by transgender men have been reported, long-term effects of testosterone therapy on fertility remain unknown. Aims: To study markers of ovarian reserve during testosterone therapy. Methods: Prospective open-label study of transgender men prior and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yaish, Iris, Malinger, Gustavo, Foad, Azem, Golani, Nechama, Yael, Sofer, Tordjman, Karen, Amir, Hadar, Greenman, Yona, Stern, Naftali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555034/ http://dx.doi.org/10.1210/js.2019-OR11-3

Ejemplares similares

OR25-5 High Prevalence of Psychopathologies Among Transgender Subjects Presenting at a Large Tertiary Transgender Health Center: Implication for the Treating Clinicians
por: Kerem, Gil, et al.
Publicado: (2019)

A Cross Sectional Analysis of the Prevalence of Co-Morbidities in Older Transgender Individuals Receiving Hormone Affirming Therapy in Comparison With the General Population
por: Breda, Ido, et al.
Publicado: (2021)

SUN-042 Low Dose Cyproterone Acetate for the Treatment of Transgender Women - a Retrospective Study
por: Even-Zohar, Naomi, et al.
Publicado: (2020)

Transgender men's preferences when choosing obstetricians and gynecologists
por: Lifshitz, Dror, et al.
Publicado: (2022)

SAT406 Evaluation Of The Emotional And Cognitive Effects Of Hormone Therapy In Transgender Men And Women
por: Yaish, Iris, et al.
Publicado: (2023)

SAT394 Over-representation Of Adoptees Among Transgender Subjects Seeking Gender-Affirming-Hormonal-Therapy (GAHT) In A Large Tertiary Medical Center
por: Yaish, Iris, et al.
Publicado: (2023)

Endocrinology specialty service for inpatients: an unmet growing need
por: Osher, Esther, et al.
Publicado: (2023)

SAT409 Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study
por: Yaish, Iris, et al.
Publicado: (2023)

SAT-194 Correlation of Capillary and Venous Plasma Measurements of Anti-Müllerian Hormone
por: Adams, Hadar, et al.
Publicado: (2019)

The Effect of the PCSK9 Inhibitor Evolocumab on Aldosterone Secretion among High Cardiovascular Risk Patients: A Pilot Study
por: Izkhakov, Elena, et al.
Publicado: (2021)

OR27-03 Duration of Testosterone-Induced Acyclicity Influences Corpora Lutea Formation and Stromal Changes in a Transgender Mouse Model
por: Kinnear, Hadrian M, et al.
Publicado: (2020)

SUN-049 Male Pattern Baldness and Waist-Hip Ratio as Markers of Arterial Stiffness in Transgender Men Undergoing Long-Term Testosterone Therapy
por: Alvares, Leonardo Azevedo Mobilia, et al.
Publicado: (2020)

FRI404 CNS Manifestations Are Linked With Hot Flashes: Analysis Of Real World Data From A Social Network
por: Shaklai, Sigal, et al.
Publicado: (2023)

SAT-037 Effect of Weight on Serum Testosterone with Subcutaneous Testosterone Enanthate in Men with Testosterone Deficiency
por: Bhattacharya, Rajib, et al.
Publicado: (2020)

Comparison of Equations Estimating Resting Metabolic Rate in Older Adults with Type 2 Diabetes
por: Buch, Assaf, et al.
Publicado: (2021)

Effect of anti-müllerian hormone on the development and selection of ovarian follicle in hens
por: Huang, S.J., et al.
Publicado: (2020)

SUN-053 Evaluation of a 52-Year-Old Transgender Man During the First Year of Testosterone Therapy - Biochemical Changes, Body Composition and Cardiovascular Aspects at the Ergometric Test: A Case Report
por: Alvares, Leonardo Azevedo Mobilia, et al.
Publicado: (2020)

Anti-Mullerian Hormone Protein-Altering Variants Are Associated With Hypertriglyceridemia in the General Population
por: Chang, Sydney, et al.
Publicado: (2021)

THU627 Fertility Outcomes And Anti Mullerian Hormone Levels In Women With Hypopituitarism
por: Fitz, Victoria W, et al.
Publicado: (2023)

SUN-229 The Role of Testosterone in Spermatogenesis: Lessons from Proteome Profiling of Human Spermatozoa in Testosterone Deficiency
por: Grande, Giuseppe, et al.
Publicado: (2019)

THU645 Comparison Of LC-MS/MS Testosterone Assays Towards Standardization Of Lower Testosterone Ranges
por: Cree, Melanie G, et al.
Publicado: (2023)

SUN-043 Galactorrhea and Hyperprolactinemia in a Transgender Female
por: Unnithan, Rachna, et al.
Publicado: (2020)

Multicenter Analysis of Cardiometabolic-Related Diagnosesin Transgender Adolescents
por: Valentine, Anna, et al.
Publicado: (2021)

LBSAT133 Dilemmas In The Diagnosis Of Osteoporosis In Transgender Population
por: Vasanthaakumar, Vijaykiran P, et al.
Publicado: (2022)

SAT-045 Free Testosterone and Cardiometabolic Parameters in Adult Men - Comparison of Algorithms for Calculation of Serum Free Testosterone
por: Holmboe, Stine Agergaard, et al.
Publicado: (2020)

OR25-4 Active Testosterone Treatment Impairs In Vitro Fertilization (IVF) Outcomes in a Female Mouse Model for Gender-Affirming Testosterone with Improvement in Outcomes Following Cessation of Testosterone Treatment
por: Moravek, Molly B, et al.
Publicado: (2022)

SAT-047 Adoption of an Age Adjusted Testosterone Reference Range Reduces Referrals to Endocrine Clinic and New Prescriptions of Testosterone
por: Dewdney, Charlotte, et al.
Publicado: (2020)

Human sex hormone-binding globulin does not provide metabolic protection against diet-induced obesity and dysglycemia in mice
por: Sofer, Yael, et al.
Publicado: (2017)

Management of Recurrent Deep Vein Thrombosis in a Transgender Woman
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

Stability of Weekly Intramuscular Estradiol Cypionate in a Transgender Woman
por: Calzada, Stephanie, et al.
Publicado: (2021)

Persistent Mullerian duct syndrome: An atypical clinical presentation
por: Tural Balsak, Belma Özlem, et al.
Publicado: (2023)

SAT-052 A Novel Oral Testosterone Therapy (TLANDO) Safely Restores Testosterone to Eugonadal Levels with Fixed Dose Treatment
por: DelConte, Anthony, et al.
Publicado: (2020)

Impact of Short-Acting vs Long-Acting Testosterone Therapy on Intratesticular Testosterone Using Data From Two Open-Label Randomized Clinical Trials of Testosterone Pellets, Injections, and Intranasal Gel in Hypogonadal Men
por: Kresch, Eliyahu, et al.
Publicado: (2021)

MON-198 Feminizing Regimen Requirements in Transgender Females Following Orchiectomy
por: Korpaisarn, Sira, et al.
Publicado: (2019)

SUN-040 Hormone Replacement Therapy in Transgender Unmasks Testicular Tumor
por: Tran, Kelvin, et al.
Publicado: (2020)

SUN-210 Testosterone Replacement Therapy Implicated in Osteonecrosis
por: Yang, Almira, et al.
Publicado: (2019)

SUN-217 Alternate Pathways of Testosterone Action in Testis
por: Talapatra, Arpita
Publicado: (2019)

FRI428 VTE And Testosterone Therapy: What Is The Risk?
por: Cheatham, Callie, et al.
Publicado: (2023)

FRI431 Erythrocytosis Associated With Oral Testosterone Replacement
por: Engel, Ashley A, et al.
Publicado: (2023)

Peripubertal Anti-Mullerian Hormone Levels Are Associated With Hyperandrogenemia During Adolescence: The Avon Longitudinal Study of Parents and Children
por: Dieguez, Abigayil, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_10sfh7mq1r964eaogkscl5093c